Jinpo Yang

418 total citations
15 papers, 286 citations indexed

About

Jinpo Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jinpo Yang has authored 15 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jinpo Yang's work include Vascular Tumors and Angiosarcomas (6 papers), Sarcoma Diagnosis and Treatment (6 papers) and Ferroptosis and cancer prognosis (4 papers). Jinpo Yang is often cited by papers focused on Vascular Tumors and Angiosarcomas (6 papers), Sarcoma Diagnosis and Treatment (6 papers) and Ferroptosis and cancer prognosis (4 papers). Jinpo Yang collaborates with scholars based in China and Germany. Jinpo Yang's co-authors include Huan Luo, Chao Ma, Feng Li, Zhichao Tian, Jiaqiang Wang, Mina Zhang, Xinhui Du, Yonghao Yang, Huijuan Wang and Chao Li and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and BMC Cancer.

In The Last Decade

Jinpo Yang

15 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinpo Yang China 11 182 153 99 71 34 15 286
Elisa Sottotetti Italy 11 106 0.6× 181 1.2× 101 1.0× 94 1.3× 25 0.7× 21 285
Neal Shiv Chawla United States 10 236 1.3× 154 1.0× 113 1.1× 61 0.9× 33 1.0× 51 424
Yueyun Chen China 9 108 0.6× 170 1.1× 71 0.7× 57 0.8× 62 1.8× 27 301
Eriseld Krasniqi Italy 10 95 0.5× 197 1.3× 93 0.9× 99 1.4× 59 1.7× 21 342
He Du China 9 79 0.4× 86 0.6× 186 1.9× 107 1.5× 61 1.8× 26 323
Yingsheng Wen China 12 155 0.9× 145 0.9× 94 0.9× 107 1.5× 23 0.7× 27 323
Yiming Zhao China 10 72 0.4× 131 0.9× 122 1.2× 64 0.9× 39 1.1× 19 293
Anna Klimczak Poland 12 202 1.1× 149 1.0× 64 0.6× 51 0.7× 17 0.5× 32 328
Elena Brozos-Vázquez Spain 10 109 0.6× 194 1.3× 56 0.6× 127 1.8× 24 0.7× 18 277

Countries citing papers authored by Jinpo Yang

Since Specialization
Citations

This map shows the geographic impact of Jinpo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinpo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinpo Yang more than expected).

Fields of papers citing papers by Jinpo Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinpo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinpo Yang. The network helps show where Jinpo Yang may publish in the future.

Co-authorship network of co-authors of Jinpo Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jinpo Yang. A scholar is included among the top collaborators of Jinpo Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinpo Yang. Jinpo Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Yang, Jinpo, et al.. (2022). Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma. Scientific Reports. 12(1). 1279–1279. 20 indexed citations
2.
Tian, Zhichao, Shuping Dong, Yang Yang, et al.. (2022). Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study. BMC Cancer. 22(1). 56–56. 14 indexed citations
3.
Tian, Zhichao, Jiaqiang Wang, Jinpo Yang, et al.. (2021). Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study. Investigational New Drugs. 39(6). 1724–1731. 1 indexed citations
4.
Li, Peng, Peng Qin, Xiaomin Fu, et al.. (2021). Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitor. Annals of Palliative Medicine. 10(3). 3039–3049. 22 indexed citations
5.
Yang, Jinpo, et al.. (2021). Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 616271–616271. 71 indexed citations
6.
7.
Wang, Huijuan, Mina Zhang, Xiaojuan Zhang, et al.. (2021). The efficacy and clinical survival outcome of different first-line treatments in EGFR-mutant non-small cell lung cancer with brain metastases.. Journal of Clinical Oncology. 39(15_suppl). 2028–2028. 1 indexed citations
8.
Ma, Zhiyong, Huijuan Wang, Chunhua Wei, et al.. (2021). Comparison of population characteristics, treatment modes, and clinical outcomes of patients with advanced non-small cell lung cancer in clinical trials and in the real world received PD-1/PD-L1 inhibitor.. Journal of Clinical Oncology. 39(15_suppl). e18733–e18733. 1 indexed citations
9.
Tian, Zhichao, Huimin Liu, Fan Zhang, et al.. (2020). Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma. Investigational New Drugs. 38(5). 1559–1569. 36 indexed citations
10.
Tian, Zhichao, Yang Yang, Yonghao Yang, et al.. (2020). High cumulative doxorubicin dose for advanced soft tissue sarcoma. BMC Cancer. 20(1). 1139–1139. 27 indexed citations
11.
Tian, Zhichao, Fan Zhang, Po Li, et al.. (2020). Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma. BMC Cancer. 20(1). 698–698. 15 indexed citations
12.
Tian, Zhichao, Yonghao Yang, Jinpo Yang, et al.. (2020). <p>Safety and Efficacy of PD-1 Inhibitors Plus Chemotherapy in Advanced Soft Tissue Sarcomas: A Retrospective Study</p>. Cancer Management and Research. Volume 12. 1339–1346. 13 indexed citations
13.
Zhang, Guowei, Ruirui Cheng, Huijuan Wang, et al.. (2020). Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study. Cancer Immunology Immunotherapy. 69(3). 399–405. 27 indexed citations
14.
Wang, Qiming, Huijuan Wang, Peng Li, et al.. (2018). Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study. Journal of Cancer Research and Clinical Oncology. 145(1). 235–240. 16 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisa Sottotetti Breakdown of academic impact, for papers by Neal Shiv Chawla Breakdown of academic impact, for papers by Yueyun Chen Breakdown of academic impact, for papers by Eriseld Krasniqi Breakdown of academic impact, for papers by He Du Breakdown of academic impact, for papers by Yingsheng Wen Breakdown of academic impact, for papers by Yiming Zhao Breakdown of academic impact, for papers by Anna Klimczak Breakdown of academic impact, for papers by Elena Brozos-Vázquez
Rankless by CCL
2026